Androgen clock reveals how hormones shape aging and health

Scientists unveil the androgen clock, a precise epigenetic tool to measure long-term androgen exposure and its role in aging and health.

EC approves Astellas’ PADCEV regimen for urothelial cancer

The approval is based on the results from the Phase III EV-302 trial of enfortumab vedotin plus pembrolizumab. Credit: Antonio Marca/Shutterstock. The European Commission (EC)

August 28, 2024

Editorial: Health studies cast shadow on weed – The Cannabist

Massachusetts has often been described as a nanny state, cosseting its citizens with overprotective policies. But sometimes the nanny takes a day off. The commonwealth

May 3, 2023

INZ-701 by Inozyme Pharma for Rickets: Likelihood of Approval – Pharmaceutical Technology

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes

October 26, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.